Protective Effects of Butyrate on Retinal Neovascularization in Preclinical Retinopathy of Prematurity Models
A. Oxenrider, T. Bui, J. Lester, G. Seth, A. J. Brokemond, M. C. Thounaojam, P. M. Martin, R. N. Jadeja
This study shows that sodium butyrate protects against retinal neovascularization in preclinical ROP models by reducing vascular, neuronal, and microglial pathology.
bioRxiv · Jun 3, 2024 · PreprintPharmacology & Toxicology